Neogenomics (NEO) Receivables - Other (2017 - 2026)

Neogenomics (NEO) has 9 years of Receivables - Other data on file, last reported at $166000.0 in Q2 2026.

• Quarterly Receivables - Other changed N/A year-over-year to $166000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $166000.0 (changed N/A YoY) and the FY2024 annual result came in at $100000.0, up 170.27% from the prior year.
• Receivables - Other climbed to $166000.0 in Q2 2026, from $100000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $2.7 million in Q3 2022 to a low of $37000.0 in Q4 2023.
• A 4-year average of $1.0 million and a median of $810000.0 in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2023 — Receivables - Other sank 98.05% — and 2024, when it jumped 170.27%.
• Tracing NEO's Receivables - Other over 4 years: stood at $1.9 million in 2022, then slumped by 98.05% to $37000.0 in 2023, then jumped by 170.27% to $100000.0 in 2024, then soared by 66.0% to $166000.0 in 2026.
• The last three Receivables - Other figures came in at $166000.0 (Q2 2026), $100000.0 (Q4 2024), and $236000.0 (Q1 2024), per Business Quant data.